Pamidronate treatment in rheumatology practice: a comprehensive review.
Pamidronate, along with other bisphosphonates, has been used for treatment of bone pain secondary to malignant involvement or metastatic disease for years. Some data, however, have also accumulated on the utility of pamidronate in a variety of benign conditions frequently handled by rheumatologists. This study aims to review the available published data regarding the potential use of pamidronate in rheumatology practice. Methods include the review of relevant articles retrieved by a PUBMED search utilizing the index term "pamidronate". All available randomized control trials, open trials, and case series, as well as properly reported case studies evaluating usage of pamidronate in rheumatic disorders, have been included in the literature review. The efficacy of pamidronate in patients with spondyloarthropathies; synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome; hypertrophic osteoarthropathy; osteoporotic vertebral fractures; chronic back pain due to disk disease or spinal stenosis; Charcot arthropathy; transient osteoporosis; and complex regional pain syndrome-I, has been demonstrated in more than 40 reports, the majority of which, however, were not controlled studies. In some of reviewed conditions, aside from providing analgesic relief, pamidronate may also have disease-modifying properties. While used in different doses in a variety of rheumatic disorders, pamidronate was generally reported to be well tolerated with an overall good safety profile. Pamidronate may represent an effective and safe choice for a spectrum of rheumatic patients, suffering from intractable musculoskeletal pain, unresponsive to traditionally recommended therapies. Large randomized, controlled studies examining the efficacy of pamidronate in the rheumatic conditions are urgently needed.
Slobodin
Gleb
G
Department of Internal Medicine A, Bnai Zion Medical Center and Ruth & Bruce Rappaport Faculty of Medicine, Technion, 47, Golomb St, Haifa 31048, Israel. gslobodin@yahoo.com
Rosner
Itzhak
I
Feld
Joy
J
Rimar
Doron
D
Rozenbaum
Michael
M
Boulman
Nina
N
Odeh
Majed
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010146:Pain / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D000077268:Pamidronate; D039781:PubMed; D016032:Randomized Controlled Trials as Topic; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D012219:Rheumatology / Q000379:methods*
D000893:Anti-Inflammatory Agents; D004164:Diphosphonates; D000077268:Pamidronate
Rheumatology (Oxford). 2000 May;39(5):567-8
10852994
Pain Med. 2004 Sep;5(3):276-80
15367305
Rheumatology (Oxford). 2004 May;43(5):658-61
14983108
Blood. 2000 Jul 15;96(2):384-92
10887096
Anticancer Drugs. 2001 Oct;12(9):731-4
11593054
Am J Med Sci. 2008 Feb;335(2):145-8
18277124
J Rheumatol. 1998 Apr;25(4):714-7
9558174
Bone. 2003 Oct;33(4):567-74
14555260
Clin Exp Rheumatol. 2006 May-Jun;24(3):348
16870109
Pain. 1998 Dec;78(3):157-169
9870569
J Obstet Gynaecol Can. 2008 Dec;30(12):1146-1148
19175968
Rheumatology (Oxford). 2002 Oct;41(10):1196-8
12364646
Joint Bone Spine. 2007 Dec;74(6):663-4
17913553
Calcif Tissue Int. 1997 Nov;61(5):386-92
9351880
Clin Rheumatol. 1997 Jan;16(1):51-6
9132326
J Rheumatol. 2001 Jan;28(1):144-55
11196517
Clin Rheumatol. 2009 Jun;28(6):715-7
19219479
Arthritis Rheum. 2002 Mar;46(3):766-73
11920413
Ann Rheum Dis. 2005 Feb;64(2):338-9
15096328
Rheumatology (Oxford). 2002 Feb;41(2):231-3
11886977
J Assoc Physicians India. 2006 Apr;54:340
16944626
Bone. 2002 Jul;31(1):96-101
12110419
J Pain Symptom Manage. 2003 Jul;26(1):678-83
12850650
Clin Rheumatol. 1999;18(3):266-7
11206358
J Pain Symptom Manage. 2002 Sep;24(3):281-4
12458105
Clin Exp Immunol. 2006 Dec;146(3):371-80
17100755
Indian J Dermatol Venereol Leprol. 2005 Jul-Aug;71(4):273-5
16394439
N Engl J Med. 1999 Mar 4;340(9):737-8
10068336
Clin J Pain. 2005 Nov-Dec;21(6):549-52
16215341
Chest. 2002 Apr;121(4):1363-4
11948079
Diabetologia. 2001 Nov;44(11):2032-7
11719835
Ann Rheum Dis. 1995 Aug;54(8):687
7677451
J Rheumatol. 2001 Dec;28(12):2754-7
11764231
Osteoporos Int. 2006;17(11):1659-65
16896508
Rheumatology (Oxford). 2003 Aug;42(8):1018-20
12869678
Joint Bone Spine. 2002 Jun;69(4):392-6
12184437
Rheumatology (Oxford). 2005 Jan;44(1):137; author reply 137-8
15611315
J Rheumatol. 1999 Aug;26(8):1856-7
10451097
Clin Exp Rheumatol. 2001 Jan-Feb;19(1):13-20
11247319
J Rheumatol. 2000 Oct;27(10):2418-23
11036839
Pharm Res. 1995 Jun;12(6):916-22
7667201
Ann Rheum Dis. 2006 May;65(5):688-9
16611869
J Foot Ankle Surg. 2004 Sep-Oct;43(5):285-9
15480402
J Bone Miner Res. 1990 Oct;5(10):1019-27
2080714
Clin Rheumatol. 2004 Aug;23(4):330-2
15293094
Rheumatology (Oxford). 2001 Dec;40(12):1394-7
11752511
J Rheumatol. 2008 Apr;35(4):707-12
18381777
Rheumatology (Oxford). 2004 Oct;43(10):1246-51
15238641
J Pediatr. 2008 Apr;152(4):571-5
18346517
Aust N Z J Med. 1997 Jun;27(3):307-10
9227815
Diabet Med. 1994 Jan-Feb;11(1):28-31
8181248
Clin Rheumatol. 2006 Sep;25(5):683-6
16391891
J Immunol. 2005 Jan 1;174(1):252-60
15611247
Pain. 2001 Apr;91(3):269-275
11275384
Rheumatology (Oxford). 2006 Mar;45(3):339-42
16249241